FDA Approves Belimumab Autoinjector for Children With Systemic Lupus Erythematosus

The approval makes belimumab (Benlysta) the first at-home treatment in its class for patients 5 years and older with systemic lupus erythematosus (SLE).

Related Keywords

United States ,America ,Maryt Crimmings , ,Lupus Foundation Of America ,Court Horncastle ,Lupus Foundation ,